Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus MD (C.IMH) affiliate files for U.S. provisional patent

Stockhouse Editorial
0 Comments| May 4, 2015

{{labelSign}}  Favorites
{{errorMessage}}

Invictus MD Strategies’ (CSE: IMH, Stock Forum) announced today that its affiliate The Edison Vape Co. had received filing confirmation of a U.S. provisional patent for the invention ‘Vaporizer Apparatus, Device and Methods’.

According to the news release, the company had recently acquired 40% of Edison Vape’s outstanding common shares with the option of purchasing the remaining 60% as outlined in a deal announced January 27, 2015.

Edison Vape is a newly formed Vancouver-based company engaged in the development and commercialization of a unique and potentially disruptive MMJ vaporizer system.

The provisional patent covers establishes an early priority date for the benefit of claiming “first to file” status against other companies or individuals that may want to file a patent with similar claims after the filing of the provisional patent.

Co-founder of The Edison Vape Co., Ryan Selby, commented, “We have been steadily advancing with the design and development of our proprietary devices and we are pleased with our progress to date.”

He went on to explain, “Our mission is to develop an effective medical grade device for the vaporization of medicinal cannabis that is as convenient, reliable, and as cost-effective as possible. In order to achieve those objectives, we are working with top-tier professionals at every level to ensure our products meet or exceed our expectations.”

Then summed up, “We anticipate the completion of initial prototypes by Summer 2015.”

Invictus MD Strategies was in the news recently when the Vancouver-based company announced a key appointment to its advisory council three days ago.

Currently there are 42.0m outstanding shares with a market cap of $6.3 million.

FULL DISCLOSURE: Invictus MD Strategies is a Stockhouse Publishing client.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company